戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 uently associated with an underlying central nervous system disorder.
2       Rabies virus (RV) infection is a fatal nervous system disorder.
3 the adult patients had an underlying central nervous system disorder.
4 search for causes of an inflammatory central nervous system disorder.
5 nt-based remedy to treat psychosis and other nervous system disorders.
6  of cell surface antibody-associated central nervous system disorders.
7 s that can potentially treat various central nervous system disorders.
8 poised to significantly reduce the burden of nervous system disorders.
9 been implicated in a wide variety of central nervous system disorders.
10  of HTR2A and serotonin signaling in central nervous system disorders.
11 ant for use in the treatment of many central nervous system disorders.
12 to treat pain, drug abuse, and other central nervous system disorders.
13  of drugs for brain tumors and other central nervous system disorders.
14 the heart of efforts to understand and treat nervous system disorders.
15 enetic and pharmacological models of central nervous system disorders.
16  agents in the treatment of multiple central nervous system disorders.
17 rmacotherapy for addiction and other central nervous system disorders.
18 y reveal white matter pathologies in central nervous system disorders.
19 re to scratch, accompanies numerous skin and nervous system disorders.
20 rapeutic target for the treatment of central nervous system disorders.
21 inhibitors as chromatin-directed therapy for nervous system disorders.
22 ent of pain, inflammation, and other central nervous system disorders.
23 e useful in the treatment of certain central nervous system disorders.
24  a neuroprotective drug for a broad range of nervous system disorders.
25 ociated with 183 disorders, of which 54 were nervous system disorders.
26 e a source of cells for treatment of central nervous system disorders.
27  use in cell replacement therapy for central nervous system disorders.
28 function, and aberrant connectivity leads to nervous system disorders.
29  role in the pathogenesis of several central nervous system disorders.
30 ion in a variety of animal models of central nervous system disorders.
31 ially affecting the onset and/or severity of nervous system disorders.
32 ext of neurobiology and the study of central nervous system disorders.
33 ects of spinal cord injury and other central nervous system disorders.
34 ful transplants for the treatment of central nervous system disorders.
35 as vectors for treating a variety of central nervous system disorders.
36 ive therapeutic targets for numerous central nervous system disorders.
37 is a definable, chronic inflammatory central nervous system disorder amenable to immunosuppressive tr
38 verexpressing human APP695 develop a central nervous system disorder and die prematurely, precluding
39 ocular motility disorders, including central nervous system disorders and peripheral cranial nerve pa
40 y studied target of gene therapy for central nervous system disorders and shares many features with p
41 ial actions may advance our understanding of nervous system disorders and suggest strategies for the
42 in depression, addictions, and other central nervous system disorders and, thus, is an important targ
43                                Although many nervous system disorders are associated with N-methyl-D-
44 r CREB may be a useful strategy for treating nervous system disorders associated with OL excitotoxici
45 argets as well as pathogenesis of peripheral nervous system disorders associated with these viruses a
46 hallenges and opportunities for ameliorating nervous-system disorders can benefit from both local and
47 ion (EPMR) is an autosomal recessive central nervous system disorder characterized by childhood onset
48 tute of Medicine's Forum on Neuroscience and Nervous System Disorders established a "Grand Challenges
49 tute of Medicine's Forum on Neuroscience and Nervous System Disorders has hosted a series of public w
50 eral nutrition (PN), cholestatic disease and nervous system disorders have been associated with high
51                            Recently, central nervous system disorders have been shown to be associate
52 , a recurrent, reversible multifocal central nervous system disorder, high-titer antiphospholipid aut
53 of COMT inhibitors in central and peripheral nervous system disorders; (ii) to provide the history an
54 nts associated with a dysmyelinating central nervous system disorder in humans.
55 ncome countries in general and for brain and nervous system disorders in particular.
56 plications in the treatment of other central nervous system disorders in which IL-1 activity has been
57 en associated with a number of human central nervous system disorders including autism spectrum disor
58 peutics for the treatment of various central nervous system disorders including drug abuse.
59 could be important in the pathophysiology of nervous system disorders including schizophrenia and mig
60 icacious in the treatment of various central nervous system disorders, including excessive daytime sl
61 iting (ten [2%] patients in each group); and nervous system disorders, including headache (19 [4%] vs
62 erapeutics for the treatment of a variety of nervous system disorders, including pain, anxiety, and P
63  treatment of various central and peripheral nervous system disorders, including Parkinson's disease,
64 on neurodegeneration associated with central nervous system disorders is examined.
65 malian nervous systems and effectively treat nervous-system disorders, it is essential to track chang
66 f NMDARs has been implicated in a variety of nervous system disorders, making them attractive therape
67 pathic Gaucher's disease and similar central nervous system disorders may benefit from this treatment
68                                    Brain and nervous system disorders may cost the United States as m
69 ), failure to thrive (n = 71), other central nervous system disorder (n = 51), head and neck cancer (
70                                              Nervous system disorders occurred in significantly more
71      The established belief that the central nervous system disorder of Niemann-Pick type C disease i
72 of relapsing autoimmune inflammatory central nervous system disorders of varying severity that is uni
73 ldren with traumatic brain injury or central nervous system disorders or children receiving cancer tr
74 anisms in subgroups of patients with central nervous system disorders, particularly those involving d
75 ical heterogeneity of paraneoplastic central nervous system disorders: Patients with a given clinical
76 that erythropoietin (EPO), a novel agent for nervous system disorders, prevents apoptotic SH-SY5Y cel
77 peutic agents for a diverse array of central nervous system disorders, pursuit of the transport prote
78  discovery, development, and translation for nervous system disorders still pose many unique challeng
79 ay be promising for the treatment of central nervous system disorders such as anxiety and depression.
80 maging tools and in the treatment of central nervous system disorders such as depression and sleep ap
81 ing pathways plays a pivotal role in central nervous system disorders, such as Alzheimer's disease (A
82  infection of macaques can result in central nervous system disorders, such as meningitis and encepha
83 have recently been clustered with a group of nervous system disorders termed protein misfolding disea
84 3% of the children had an underlying central nervous system disorder that coincided with the onset of
85 n isotype III, result in a spectrum of human nervous system disorders that we now call the TUBB3 synd
86 aining in the diagnosis and treatment of the nervous system disorders which are encountered daily.
87 yndrome (OMS) is a severe autoimmune central nervous system disorder, which predominantly affects you
88 Stiff-person syndrome is a disabling central nervous system disorder with no satisfactory treatment t
89 r after spinal cord injury and other central nervous system disorders with a demyelinating pathology.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。